Analysis of gene expression profiles reveals novel correlations with the clinical course of colorectal cancer

Oncology Research

Volumn 16, Issue 11, 2007, Pages 535-548

  Cavalieri, Duccio ^a   Dolara, Piero ^a   Mini, Enrico ^a,c   Luceri, Cristina ^a   Castagnini, Cinzia ^a   Toti, Simona ^a   Maciag, Karolina ^a   De Filippo, Carlotta ^a   Nobili, Stefania ^a   Morganti, Maria ^a   Napoli, Cristina ^a   Tonini, Giulia ^a   Baccini, Michela ^a   Biggeri, Annibale ^a   Tonelli, Francesco ^a   Valanzano, Rosa ^a   Orlando, Claudio ^a   Gelmini, Stefania ^a   Cianchi, Fabio ^a   Messerini, Luca ^a   Luzzatto, Lucio ^b   more..

^a UNIVERSITY OF FLORENCE   (Italy)

^b ISTITUTO TOSCANO TUMORI   (Italy)

^c Department of Pharmacology ^*  (Italy)

Author keywords

Colorectal cancer prognosis; Gene expression; Microarrays; Real time RT PCR

Indexed keywords

AMINO ACID; BETA2 INTEGRIN; CARBON; COMPLEMENTARY DNA; FIBROBLAST GROWTH FACTOR RECEPTOR; GENE PRODUCT; JANUS KINASE 3; MITOCHONDRIAL RIBOSOMAL PROTEIN S11; NATRIURETIC PEPTIDE RECEPTOR A; NITROGEN; PHD FINGER PROTEIN 10; POTASSIUM CHANNEL KCNK3 PROTEIN; PROSTASIN; RNA; THIOREDOXIN LIKE 2 PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER SURGERY; CANCER SURVIVAL; CARBON METABOLISM; COLORECTAL CANCER; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; DNA MICROARRAY; FEMALE; GENE EXPRESSION; GENE IDENTIFICATION; GENETIC ANALYSIS; GENETIC TRANSCRIPTION; HUMAN; HUMAN TISSUE; MALE; MATHEMATICAL ANALYSIS; NITROGEN METABOLISM; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; REAL TIME POLYMERASE CHAIN REACTION;

EID: 38949207223     PISSN: 09650407     EISSN: None     Source Type: Journal    
DOI: 10.3727/096504007783438376     Document Type: Article

References (34)

1. Vogelstein, B.; Fearon, E. R.; Hamilton, S. R.; Kern, S. E.; Preisinger, A. C.; Leppert, M.; Nakamura, Y.; White, R.; Smits, A. M.; Bos, J. L. Genetic alterations during colorectal-tumor development. N. Engl. J. Med. 319:525-532; 1988.
2. Fearon, E. R.; Vogelstein, B. A genetic model for colorectal tumorigenesis. Cell 61:759-767; 1990.
3. Alon, U.; Barkai, N.; Notterman, D. A.; Gish, K.; Ybarra, S.; Mack, D.; Levine, A. J. Broad patterns of gene expression revealed by clustering analysis of tumor and normal colon tissues probed by oligonucleotide arrays. Proc. Natl. Acad. Sci. USA 96:6745-6750; 1999.
4. Backert, S.; Gelos, M.; Kobalz, U.; Hanski, M. L.; Bohm, C.; Mann, B.; Lovin, N.; Gratchev, A.; Mansmann, U.; Moyer, M. P.; Riecken, E. O.; Hanski, C. Differential gene expression in colon carcinoma cells and tissues detected with a cDNA array. Int. J. Cancer 82:868-874; 1999.
5. Hegde, P.; Qi, R.; Gaspard, R.; Abernathy, K.; Dharap, S.; Earle-Hughes, J.; Gay, C.; Nwokekeh, N. U.; Chen, T.; Saeed, A. I.; Sharov, V.; Lee, N. H.; Timothy, J.; Yeatman, T. J.; Quackenbush, J. Identification of tumor markers in models of human colorectal cancer using a 19.200-element complementary DNA microarray. Cancer Res. 61:7792-7797; 2001.
6. Takemasa, I.; Higuchi, H.; Yamamoto, H.; Sekimoto, M.; Tomita, N.; Nakamori, S.; Matoba, R.; Monden, M.; Matsubara, K. Construction of preferential cDNA microarray specialized for human colorectal carcinoma: Molecular sketch of colorectal cancer. Biochem. Biophys. Res. Commun. 285:1244-1249; 2001.
7. Williams, N. S.; Gaynor, R. B.; Scoggin, S.; Verma, U.; Gokaslan, T.; Simmang, C.; Fleming, J.; Tavana, D.; Frenkel, E.; Becerra, C. Identification and validation of genes involved in the pathogenesis of colorectal cancer using cDNA microarrays and RNA interference. Clin. Cancer Res. 9:931-946; 2003.
8. Notterman, D. A.; Alon, U.; Sierk, A. J.; Levine, A. J. Transcriptional gene expression profiles of colorectal adenoma, adenocarcinoma, and normal tissue examined by oligonucleotide arrays. Cancer Res. 61:3124-3130; 2001.
9. Birkenkamp-Demtroder, K.; Christensen, L. L.; Olesen, S. H.; Frederiksen, C. M.; Laiho, P.; Aaltonen, L. A.; Laurberg, S.; Sorensen, F. B.; Hagemann, R.; Orntoft, T. F. Gene expression in colorectal cancer. Cancer Res. 62:4352-4363; 2002.
10. Croner, R. S.; Peters, A.; Brueckl, W. A.; Matzel, K. E.; Klein-Hitpass, L.; Brabletz, T.; Papadopoulos, T.; Hohenberger, W.; Reingruber, B.; Lausen, B. Microarray versus conventional prediction of lymph node metastasis in colorectal carcinoma. Cancer 104:395-404; 2005.
11. Croner, R. S.; Foertsch, T.; Brueckl, W. M.; Guenther, K.; Siebenhaar, R.; Stremmel, C.; Matzel, K. E.; Papadopoulos, T.; Kirchner, T.; Behrens, J.; Klein-Hitpass, L.; Stuerzl, M.; Hohenberger, W.; Reingruber, B. Common denominator genes that distinguish colorectal carcinoma from normal mucosa. Int. J. Colorectal Dis. 20:353-362; 2005.
12. Kitahara, O.; Furukawa, Y.; Tanaka, T.; Kihara, C.; Ono, K.; Yanagawa, R.; Nita, M. E.; Takagi, T.; Nakamura, Y.; Tsunoda, T. Alterations of gene expression during colorectal carcinogenesis revealed by cDNA microarrays after laser-capture microdissection of tumor tissues and normal epithelia. Cancer Res. 61:3544-3549; 2001.
13. Lin, Y. M.; Furukawa, Y.; Tsunoda, T.; Yue, C. T.; Yang, K. C.; Nakamura, Y. Molecular diagnosis of colorectal tumors by expression profiles of 50 genes expressed differentially in adenomas and carcinomas. Oncogene 21:4120-4128; 2002.
14. Agrawal, D.; Chen, T.; Irby, R.; Quackenbush, J.; Chambers, A. F.; Szabo, M.; Cantor, A.; Coppola, D.; Yeatman, T. J. Osteopontin identified as lead marker of colon cancer progression, using pooled sample expression profiling. J. Natl. Cancer Inst. 94:513-521; 2002.
15. Zou, T. T.; Selaru, F. M.; Xu, Y.; Shustova, V.; Yin, J.; Mori, Y.; Shibata, D.; Sato, F.; Wang, S.; Olaru, A.; Deacu, E.; Liu, T. C.; Abraham, J. M.; Meltzer, S. J. Application of cDNA microarrays to generate a molecular taxonomy capable of distinguishing between colon cancer and normal colon. Oncogene 21:4855-4862; 2002.
16. Frederiksen, C. M.; Knudsen, S.; Laurberg, S.; Orntoft, T. F. Classification of Dukes' B and C colorectal cancers using expression arrays. J. Cancer Res. Clin. Oncol. 129:263-271; 2003.
17. Tureci, O.; Ding, J.; Hilton, H.; Bian, H.; Ohkawa, H.; Braxenthaler, M.; Seitz, G.; Raddrizzani, L.; Friess, H.; Uchle, M.; Sahin, U.; Hammer, J. Computational dissection of tissue contamination for identification of colon cancer-specific expression profiles. FASEB J. 17:376-385; 2003.
18. Eschrich, S.; Yang, I.; Bloom, G.; Kwong, K. J.; Boulware, D.; Cantor, A.; Coppola, D.; Kruhøffer, M.; Aaltonen, L.; Orntoft, T. F.; Quackenbush, J.; Yeatman, T. J. Molecular staging for survival prediction of colorectal cancer patients. J. Clin. Oncol. 23:3526-3535; 2005.
19. Wang, Y.; Jatkoe, T.; Zhang, Y.; Mutch, M. G.; Talantov, D.; Jiang, J.; McLeod, H. L.; Atkins, D. Gene expression profiles and molecular markers to predict recurrence of Dukes' B colon cancer. J. Clin. Oncol. 22:1564-1571; 2004.
20. Arango, D.; Laiho, P.; Kokko, A.; Alhopuro, P.; Sammalkorpi, H.; Salovaara, R.; Nicorici, D.; Hautniemi, S.; Alazzouzi, H.; Mecklin, J. P.; Jarvinen, H.; Hemminki, A.; Astola, J.; Schwarz, S.; Aaltonen, L. Gene-expression profiling predicts recurrence in Dukes' C colorectal cancer. Gastroenterology 129:874-884; 2005.
21. Bertucci, F.; Salas, S.; Eysteries, S.; Nasser, V.; Finetti, P.; Ginestier, C.; Charafe-Jauffret, E.; Loriod, B.; Bachelart, L.; Montfort, J.; Victorero, G.; Viret, F.; Ollendorff, V.; Fert, V.; Giovaninni, M.; Delpero, J-R.; Nguyen, C.; Viens, P.; Monges, G.; Birnbaum, D.; Houlgatte, R. Gene expression profiling of colon cancer by DNA microarrays and correlation with histoclinical parameters. Oncogene 23:1377-1391; 2004.
22. Barrier, A.; Boelle, P. Y.; Lemoine, A.; Tse, C.; Brault, D.; Chiappini, F.; Lacaine, F.; Houry, S.; Huguier, M.; Flahault, A.; Dudoit, S. Gene expression profiling of non-neoplastic mucosa may predict clinical outcome of colon cancer patients. Dis. Colon Rectum 48:2238-2248; 2005.
23. Barrier, A.; Boelle, P. Y.; Roser, F.; Gregg, J.; Tse, C.; Brault, D.; Chiappini, F.; Lacaine, F.; Houry, S.; Huguier, M.; Franc, B.; Flahault, A.; Lemoine, A.; Dudoit, S. Stage II colon cancer prognosis prediction by tumor gene expression profiling. J. Clin. Oncol. 24:4685-4691; 2006.
24. Johnston, P. G.; Mulligan, K.; Kai, E.; Black, J.; Moore, S.; Ma Dermott, U.; Wilson, R.; Harkin, D. A genetic signature of relapse in stage II colorectal cancer derived from formalin fixed embedded tissue (FFPA) using a unique disease specific colorectal array. J. Clin. Oncol. 24:3519; 2006.
25. Kaufman, L.; Rousseuw, P. J. Finding groups in data. New York: John Wiley & Sons; 1990.
26. Tusher, V. G.; Tibshirani, R.; Chu, G. Significance analysis of microarrays applied to the ionizing radiation response. Proc. Natl. Acad. Sci. USA 98:5116-5121; 2001.
27. Storey, J. D. A direct approach to false discovery rates. J. R. Stat. Soc. B 64:479-498; 2002.
28. Cox, D. R. Regression models and life tables. J. R. Stat. Soc. B 34:187-220; 1972.
29. Dempster, A. P.; Laird, N. M.; Rubin, D. B. Maximum likelihood from incomplete data via the em algorithm. J. R. Stat. Soc. B 39:1-38; 1977.
30. McLachlan, G.; Peel, P. Finite mixture models. New York: John Wiley & Sons; 2000.
31. Cavalieri, D.; Castagnini, C.; Toti, S.; Maciag, K.; Kelder, T.; Gambineri, L.; Angioli, S.; Dolara, P. Eu.Gene Analyzer a tool for integrating gene expression data with pathway databases. Bioinformatics 23:2631-2632; 2007.
32. Subramanian, A.; Tamayo, P.; Mootha, V. K.; Mukherjee, S.; Ebert, B. L.; Gillette, M. A.; Paulovich, A.; Pomeroy, S. L.; Golub, T. R.; Lander, E. S.; Mesirov, J. P. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA 102(43):15545-15550; 2005.
33. Ein-Dor, L.; Zuk, O.; Domany, E. Thousands of samples are needed to generate a robust gene list for predicting outcome in cancer. Proc. Natl. Acad. Sci. USA 103(15):5923-5928; 2006.
34. Bange, J.; Prechtl, D.; Cheburkin, Y.; Specht, K.; Harbeck, N.; Schmitt, M.; Knyazeva, T.; Müller, S.; Gärtner, S.; Sures, I.; Wang, H.; Imyanitov, E.; Häring, H. U.; Knayzev, P.; Iacobelli, S.; Höfler, H.; Ullrich, A. Cancer progression and tumor cell motility are associated with the FGFR4 Arg(388) allele. Cancer Res. 62(3):840-847; 2002.